30 reviews in English, 18 reviews in Japanese (Until the year 2023)
1. Sakuma K, Hamada K, Yamaguchi A, Aoi W. Current Nutritional and Pharmacological Approaches for
Attenuating Sarcopenia. Cells 12(19): 2422, 2023
2. Sakai K, Nakayama E, Yoneoka D, Sakata N, Iijima K, Tanaka T, Hayashi K, Sakuma K, Hoshino E.
Association of Oral Function and Dysphagia with Frailty and Sarcopenia in Community-Dwelling Older Adults:
A Systematic Review and Meta-Analysis. Cells 11(14): 2199, 2022
3. Matsuo, H, Sakuma, K. Pathophysiology of cachexia and characteristics of dysphagia in chronic diseases.
Asia Pac J Oncol Nurs 9(10): 100120, 2022
4. Sakuma K, Yamaguchi A. Recent advances in pharmacological, hormonal, nutritional intervention for
sarcopenia. Pflügers Archiv 470: 449-460, 2018
5. Sakuma K, Aoi W, Yamaguchi A. Molecular mechanism of sarcopenia and cachexia: recent research advances.
Pflügers Archiv 469: 573-591, 2017
6. Sakuma K, Aoi W, Yamaguchi A. Current understanding of sarcopenia: possible candidates modulating muscle
mass. Pflügers Archiv 467: 213-229, 2015
7. Wakabayashi H, Sakuma K. Rehabilitation nutrition for sarcopenia with disability: a combination of both
rehabilitation and nutrition care management. J Cachexia Sarcopenia Muscle 5: 269-277, 2014
8. Sakuma
K, Aoi W, Yamaguchi A. The intriguing regulators of muscle mass in
sarcopenia and muscular
dystrophy. Front Aging Neurosci 6: Article ID 230, 17 pages, 2014
9. Wagatsuma A, Sakuma K. Vitamin D signaling in myogenesis: potential for treatment of sarcopenia. Biomed Res
Int 2014: Article ID 121254, 13 pages, 2014
10. Wakabayasi H, Sakuma K. Comprehensive approach to sarcopenia treatment. Curr Clin Pharmacol 9: 171-180,
11. Aoi W, Sakuma K. Does regulation of skeletal muscle function involve circulating microRNAs? Front Physiol 5:
12. Sakuma K, Yamaguchi A. Sarcopenic obesity and endocrinal adaptation with age. Int J Endocrinol 2013: Article
13. Suwa M, Sakuma K. The potential role of sirtuins regarding the effects of exercise on aging-related diseases.
Curr Aging Sci 6: 178-188, 2013
14. Aoi W, Sakuma K. Skeletal muscle: novel and intriguing characteristics as a secretory organ. Biodiscovery 7:
2, 9 pages, 2013
15. Sakuma K, Yamaguchi A. Serum response factor (SRF)-dependent signaling in regenerating, hypertrophied,
and pathological skeletal muscle. Front Pathol Genet 1: 1-8, 2013
16. Wagatsuma A, Sakuma K. Mitochondria as a potential regulator of myogenesis. Scientific World Journal 2013:
Article ID 593267, 9 pages, 2013
17. Kano Y, Sakuma K. Effect of aging on the relationship between capillary supply and muscle fiber size.
18. Wakabayashi H, Sakuma K. Nutrition, exercise, and pharmaceutical therapies for sarcopenic obesity.
19. Sakuma K, Yamaguchi A : Recent research developments in regeneration of skeletal muscle. J Phys Fitness
Sports Med 1:
401-411
20. Sakuma
K, Yamaguchi A. Molecular determinants of skeletal muscle hypertrophy.
J Sports Med & Doping
21. Sakuma K, Yamaguchi A. Sarcopenia and age-related endocrine function. Int J Endocrinol 2012: Article ID
22. Sakuma K, Yamaguchi A. Novel intriguing strategies attenuating sarcopenia. J Aging Res 2012: Article ID
23. Wagatsuma A, Sakuma K. Molecular mechanisms for age-associated mitochondrial deficiency in skeletal
muscle. J Aging Res 2012: Article ID 768304, 14 pages, 2012
24. Sakuma K, Yamaguchi A. Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle
mass. J Cachexia Sarcopenia Muscle 3: 77-94, 2012
25. Sakuma K, Yamaguchi A: Current application of cyclosporine A to investigate skeletal muscle adaptation. Curr
Enzyme Inhibit 7: 154-162, 2011
26. Sakuma K, Yamaguchi A : The recent understanding of the neurotrophin's role in skeletal muscle adaptation.
J Biomed Biotechnol 2011: Article ID 201696, 12 pages, 2011
27. Sakuma K, Yamaguchi A : Inhibitors of myostatin- and proteasome-dependent signaling for attenuating muscle
wasting. Recent Pat Regen Med 1: 284-298, 2011
28. Aoi W, Sakuma K. Oxidative stress and skeletal muscle dysfunction with aging. Curr Aging Sci 4: 101-109,
2011.
29. Sakuma K, Yamaguchi A. The functional role of calcineurin in hypertrophy, regeneration, and disorders of
skeletal muscle. J Biomed Biotechnol 2010: Article ID 721219, 2010
30. Sakuma K, Yamaguchi A. Molecular mechanisms in aging and current strategies to counteract sarcopenia.
Curr Aging Sci 3: 90-101, 2010
1. 佐久間邦弘. 筋肉の異化と同化. 腎と透析 90: 329-333, 2021
2. 佐久間邦弘. カヘキシアにおけるサルコペニアの分子機構. 医学のあゆみ 274: 563-566, 2020
3. 佐久間邦弘. サルコペニアの病態生理. Medical Practice 37: 689-693, 2020
4. 佐久間邦弘. 細胞機能の恒常性. 体育の科学 70: 107-111, 2020
5. 佐久間邦弘. タンパク分解とサルコペニアの機構. Geriatric Medicine 57: 775-779, 2019
6. 佐久間邦弘. 高齢者にアミノ酸の摂取は有効か. 介護予防・健康づくり 6: 47-48, 2019
7. 佐久間邦弘. サルコペニア発症の分子機構. 日本サルコペニア・フレイル学会雑誌 1: 19-22, 2017
8. 佐久間邦弘. サルコペニアとオートファジー. 食と医療 1: 78-85, 2017
9. 佐久間邦弘. サルコペニアの分子制御機構. BioClinica 31: 18-22, 2016
10. 佐久間邦弘. フレイルとサルコペニア. Anti-Aging Medicine, 12: 38-44, 2016
11. 佐久間邦弘. 運動による骨格筋の分化・再生に働く制御機構. 体育の科学 66: 653-658, 2016
12. 佐久間邦弘. サルコペニア発症の分子機構. 腎と透析 80: 612-616, 2016
13. 佐久間邦弘. サルコペニア発症の分子機序. 最新医学別冊 診断と治療のABC, p. 25-31, 2016
14. 佐久間邦弘. サルコペニアの発症機構. 最新医学 70: 51-57, 2015
15. 佐久間邦弘. サルコペニアの発症メカニズム. Geriatric Medicine 52: 337-341, 2014
16. 佐久間邦弘. 遺伝子からみた筋肥大と筋萎縮. 体育の科学 55: 584-590, 2005
17. 佐久間邦弘. 筋線維組成・筋肥大を規定する遺伝子. 体育の科学 51: 678-683, 2001
18. 戸塚武, 渡辺貴美, 佐久間邦弘, 浦本勲. 筋ジストロフィー症は筋成長障害 (逆説) 成長指向性の善玉病変.
臨床検査 44: 445-449, 2000